Takeda Pharmaceutical Co Ltd (TAK)
13.08
-0.09
(-0.68%)
USD |
NYSE |
Apr 30, 16:00
13.08
0.00 (0.00%)
After-Hours: 16:30
Takeda Pharmaceutical Profit Margin (Quarterly): 9.51% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 9.51% |
| September 30, 2023 | -4.60% |
| June 30, 2023 | 8.44% |
| March 31, 2023 | 3.26% |
| December 31, 2022 | 10.86% |
| September 30, 2022 | 6.16% |
| June 30, 2022 | 10.80% |
| March 31, 2022 | -1.30% |
| December 31, 2021 | 6.41% |
| September 30, 2021 | 5.44% |
| June 30, 2021 | 14.50% |
| March 31, 2021 | 25.59% |
| December 31, 2020 | 11.04% |
| September 30, 2020 | 0.51% |
| June 30, 2020 | 10.29% |
| March 31, 2020 | 0.22% |
| December 31, 2019 | -3.75% |
| September 30, 2019 | 8.35% |
| June 30, 2019 | 0.83% |
| March 31, 2019 | -4.08% |
| December 31, 2018 | 7.56% |
| September 30, 2018 | 11.24% |
| June 30, 2018 | 17.39% |
| March 31, 2018 | -13.47% |
| December 31, 2017 | 13.95% |
| Date | Value |
|---|---|
| September 30, 2017 | 6.47% |
| June 30, 2017 | 32.30% |
| March 31, 2017 | -12.19% |
| December 31, 2016 | 8.90% |
| September 30, 2016 | 5.94% |
| June 30, 2016 | 22.93% |
| March 31, 2016 | -8.08% |
| December 31, 2015 | 12.11% |
| September 30, 2015 | 6.51% |
| June 30, 2015 | 5.51% |
| March 31, 2015 | -51.51% |
| December 31, 2014 | 3.75% |
| September 30, 2014 | 6.37% |
| June 30, 2014 | 8.12% |
| March 31, 2014 | -6.58% |
| December 31, 2013 | 11.89% |
| September 30, 2013 | 10.25% |
| June 30, 2013 | 8.76% |
| March 31, 2013 | 2.63% |
| December 31, 2012 | 4.75% |
| September 30, 2012 | 8.29% |
| June 30, 2012 | 21.98% |
| March 31, 2012 | -9.56% |
| December 31, 2011 | 5.87% |
| September 30, 2011 | 17.40% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-4.60%
Minimum
Sep 2023
25.59%
Maximum
Mar 2021
6.45%
Average
6.41%
Median
Dec 2021
Profit Margin (Quarterly) Benchmarks
| Hoya Corp | 19.43% |
| Astellas Pharma Inc | 3.44% |
| Nxera Pharma Co Ltd | -2.85% |
| PeptiDream Inc | -8.20% |
| Stemcell Holdings Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 2.67% |
| Return on Assets | 1.24% |
| Return on Invested Capital | 1.59% |
| Gross Profit Margin (Quarterly) | 65.85% |
| Operating Margin (Quarterly) | 5.98% |
| Return on Net Operating Assets | 1.38% |